These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28695310)

  • 1. Central aortic pulse pressure, thrombogenicity and cardiovascular risk.
    Chen G; Bliden KP; Chaudhary R; Liu F; Kaza H; Navarese EP; Tantry US; Gurbel PA
    J Thromb Thrombolysis; 2017 Aug; 44(2):223-233. PubMed ID: 28695310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombogenicity and central pulse pressure to enhance prediction of ischemic event occurrence in patients with established coronary artery disease: The MAGMA-ischemia score.
    Bliden KP; Chaudhary R; Navarese EP; Sharma T; Kaza H; Tantry US; Gurbel PA
    Atherosclerosis; 2018 Jan; 268():55-62. PubMed ID: 29175655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography: A Novel Prothrombotic Marker of Coronary Artery Stent Restenosis.
    Bliden KP; Tantry US; Gesheff MG; Franzese CJ; Pandya S; Toth PP; Mathew DP; Chaudhary R; Gurbel PA
    J Interv Cardiol; 2016 Apr; 29(2):168-78. PubMed ID: 26822493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study.
    Gurbel PA; Bliden KP; Saucedo JF; Suarez TA; DiChiara J; Antonino MJ; Mahla E; Singla A; Herzog WR; Bassi AK; Hennebry TA; Gesheff TB; Tantry US
    J Am Coll Cardiol; 2009 Feb; 53(8):648-57. PubMed ID: 19232896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of weight gain with coronary artery disease, inflammation and thrombogenicity.
    Chaudhary R; Bliden KP; Tantry US; Mohammed N; Mathew D; Gesheff MG; Franzese CJ; Gurbel PA
    J Thromb Thrombolysis; 2016 Apr; 41(3):394-403. PubMed ID: 26714821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The link between heightened thrombogenicity and inflammation: pre-procedure characterization of the patient at high risk for recurrent events after stenting.
    Gurbel PA; Bliden KP; Kreutz RP; Dichiara J; Antonino MJ; Tantry US
    Platelets; 2009 Mar; 20(2):97-104. PubMed ID: 19235051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in thrombogenicity among patients with angina and non-obstructive coronary artery disease.
    Chaudhary R; Sukhi A; Chaudhary R; Jindal M; Vyas A; Rout A; Bliden K; Tantry U; Gurbel P
    J Thromb Thrombolysis; 2019 Oct; 48(3):373-381. PubMed ID: 31218482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?
    Gurbel PA; Bliden KP; Levy JH; Walia N; Rapista N; Cho A; Jerjian C; Tantry US
    Blood Coagul Fibrinolysis; 2021 Dec; 32(8):544-549. PubMed ID: 34369413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombelastography maximal clot strength could predict one-year functional outcome in patients with ischemic stroke.
    Yao X; Dong Q; Song Y; Wang Y; Deng Y; Li Y
    Cerebrovasc Dis; 2014; 38(3):182-90. PubMed ID: 25300785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S; Hansen TW; Rossing P
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachial-ankle pulse wave velocity and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes in Korea: A comparable and additive study.
    Seo HJ; Ki YJ; Han MA; Choi DH; Ryu SW
    Platelets; 2015; 26(7):665-71. PubMed ID: 25383727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Cholinesterase Levels Are Associated With 2-Year Ischemic Outcomes After Angioplasty and Stenting for Peripheral Artery Disease.
    Gremmel T; Wadowski PP; Mueller M; Kopp CW; Koppensteiner R; Panzer S
    J Endovasc Ther; 2016 Oct; 23(5):738-43. PubMed ID: 27328913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights.
    Chan YH; Hai JJ; Lau KK; Li SW; Lau CP; Siu CW; Yiu KH; Tse HF
    BMC Cardiovasc Disord; 2017 Aug; 17(1):233. PubMed ID: 28836952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor marker carbohydrate antigen 125 predicts adverse outcome after transcatheter aortic valve implantation.
    Husser O; Núñez J; Núñez E; Holzamer A; Camboni D; Luchner A; Sanchis J; Bodi V; Riegger GA; Schmid C; Hilker M; Hengstenberg C
    JACC Cardiovasc Interv; 2013 May; 6(5):487-96. PubMed ID: 23702013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting.
    Ezhov MV; Safarova MS; Afanasieva OI; Kukharchuk VV; Pokrovsky SN
    Atherosclerosis; 2014 Aug; 235(2):477-82. PubMed ID: 24952151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting.
    Gurbel PA; Bliden KP; Cohen E; Navickas IA; Singla A; Antonino MJ; Fissha M; Kreutz RP; Bassi AK; Tantry US
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):268-75. PubMed ID: 18469547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin.
    Bliden KP; Singla A; Gesheff MG; Toth PP; Tabrizchi A; Ens G; Guyer K; Singh M; Franzese CJ; Stapleton D; Tantry US; Gurbel PA
    Thromb Haemost; 2014 Aug; 112(2):323-31. PubMed ID: 24763965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease.
    Chirinos JA; Zambrano JP; Chakko S; Veerani A; Schob A; Willens HJ; Perez G; Mendez AJ
    Hypertension; 2005 May; 45(5):980-5. PubMed ID: 15837821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central aortic pressure and long-term outcome in hypertensive patients undergoing percutaneous coronary intervention.
    Wu HP; Lin MJ
    Sci Rep; 2020 Oct; 10(1):17420. PubMed ID: 33060829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.